S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
OTCMKTS:INBP

Integrated BioPharma (INBP) Stock Price, News & Analysis

$0.22
0.00 (0.00%)
(As of 03/28/2024 ET)
Today's Range
$0.22
$0.22
50-Day Range
$0.20
$0.25
52-Week Range
$0.17
$0.40
Volume
N/A
Average Volume
1,380 shs
Market Capitalization
$6.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
INBP stock logo

About Integrated BioPharma Stock (OTCMKTS:INBP)

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

INBP Stock Price History

INBP Stock News Headlines

Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
What Is a Vertically Integrated Business Model?
Integrated BioPharma reports results
Your Money is Not Safe
Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…
Maricopa Integrated Health System-Phoenix
Integrated BioPharma GAAP EPS of $0.05, revenue of $13.27M
Integrated Biopharma Inc
Integrated BioPharma Announces Change in Directors
See More Headlines
Receive INBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/12/2024
Today
3/29/2024
Next Earnings (Estimated)
5/06/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:INBP
Employees
141
Year Founded
N/A

Profitability

Net Income
$-30,000.00
Pretax Margin
-0.73%

Debt

Sales & Book Value

Annual Sales
$50.67 million
Cash Flow
$0.04 per share
Book Value
$0.63 per share

Miscellaneous

Free Float
16,374,000
Market Cap
$6.61 million
Optionable
Not Optionable
Beta
0.52
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Ms. Riva Kay Sheppard (Age 57)
    Co-CEO & Director
    Comp: $257.82k
  • Ms. Christina Kay (Age 54)
    Co-CEO & Director
    Comp: $253.09k
  • Ms. Dina L. Masi (Age 63)
    Senior VP, CFO & Secretary
    Comp: $281.29k
  • Mr. Jamie E. Levey
    Head of Investor Relations

INBP Stock Analysis - Frequently Asked Questions

How have INBP shares performed in 2024?

Integrated BioPharma's stock was trading at $0.2452 on January 1st, 2024. Since then, INBP stock has decreased by 10.4% and is now trading at $0.2196.
View the best growth stocks for 2024 here
.

When is Integrated BioPharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our INBP earnings forecast
.

How were Integrated BioPharma's earnings last quarter?

Integrated BioPharma, Inc. (OTCMKTS:INBP) announced its earnings results on Monday, February, 12th. The company reported ($0.01) EPS for the quarter. The company earned $11.51 million during the quarter. Integrated BioPharma had a negative net margin of 0.76% and a negative trailing twelve-month return on equity of 2.05%.

How do I buy shares of Integrated BioPharma?

Shares of INBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:INBP) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners